GlassScriptPhysician profile
Reid A Goodman
NPI 1093728305
$1,071.18
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $78.97 · 2021: $317 · 2022: $379.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $145.23 | 2019-2022 | |
| Therapeuticsmd, INC. | $144.88 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $135.61 | 2021-2022 | |
| Abbvie INC. | $115.99 | 2019-2022 | |
| Coopersurgical, INC. | $79.00 | 2019-2022 | |
| Pfizer INC. | $65.93 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $56.26 | 2021-2022 | |
| Medtronic, INC. | $46.13 | 2022 | |
| Hologic Sales and Service, LLC | $40.24 | 2022 | |
| Vertical Pharmaceuticals, LLC | $39.54 | 2019-2020 | |
| Organon LLC | $35.49 | 2021-2022 | |
| Coloplast Corp | $27.03 | 2022 | |
| Amag Pharmaceuticals, INC. | $18.26 | 2020 | |
| Ascend Therapeutics US, LLC | $18.00 | 2021 | |
| Evofem Biosciences, INC. | $17.98 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $17.22 | 2022 | |
| Myovant Sciences INC. | $16.50 | 2021 | |
| Covidien LP | $15.12 | 2019 | |
| Allergan, INC. | $13.10 | 2019 | |
| Exeltis, USA INC. | $11.92 | 2019 | |
| Dysis Medical, INC. | $11.75 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reid Goodman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.